Olea europaea Leaf Extract Improves the Efficacy of Temozolomide Therapy by Inducing MGMT Methylation and Reducing P53 Expression in Glioblastoma

References

• Kleihues P, Louis DN, Wiestler OD, Burger PC, and Scheithauer BW: WHO grading of tumours of the central nervous system. In: WHO Classification of Tumours of the Central Nervous System, 4th ed. Louis DN, Ohgaki H and Wiestler OD (eds.). Lyon: International Agency for Research on Cancer, 2007, pp. 10–11.
   Google Scholar
• Linz U: Commentary on effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10, 459–466, 2009.
   PubMed Web of Science ®Google Scholar
• Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, et al.: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. J Rad Onc Biol Phys 18, 321–324, 1990.
   PubMed Web of Science ®Google Scholar
• Fukushima T, Takeshima H, and Kataoka H: Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. Anticancer Res 29, 4845–4854, 2009.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987–996, 2005.
   PubMed Web of Science ®Google Scholar
• Denny BJ, Wheelhouse RT, Stevens MF, Tsang LL, and Slack JA: NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry 33, 9045–9051, 1994.
   PubMed Web of Science ®Google Scholar
• Clark AS, Deans B, Stevens MF, Tisdale MJ, Wheelhouse RT, et al.: Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide. J Med Chem 38, 1493–1504, 1995.
   PubMed Web of Science ®Google Scholar
• Friedman HS, Kerby T, and Calvert H. Temozolomide and treatment of malignant glioma. Clin Cancer Res 6, 2585–2597, 2000.
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, et al.: Clinical trial substantiates the predictive value of O6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10, 1871–1874, 2004.
   PubMed Web of Science ®Google Scholar
• Wang Y, Kato T, Ayaki H, Ishizaki K, Tano K, et al.: Correlation between DNA methylation and expression of O6-methylguanine-DNA methyltransferase gene in cultured human tumor cells. Mutat Res 273, 221–230, 1992.
   PubMed Web of Science ®Google Scholar
• Costello JF, Futscher BW, Tano K, Graunke DM, and Pieper RO: Graded methylation in the promoter and in the body of the O6-methylguanine-DNA methyltransferase gene correlates with MGMT expression in human glioma cells. Cancer Res 56, 13916–13924, 1996.
   Google Scholar
• Esteller M, Hamilton SR, Burger PC, Baylin SB, and Herman JG: Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59, 793–797, 1999.
   PubMed Web of Science ®Google Scholar
• Estellar M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, et al.: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343, 1350–1354, 2000.
   PubMed Web of Science ®Google Scholar
• Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, et al.: CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Clin Cancer Res 10, 4933–4938, 2004.
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, et al.: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352, 997–1003, 2005.
   PubMed Web of Science ®Google Scholar
• Verbeek B, Southgate TD, Gilham DE, and Margison GP: O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy. Br Med Bull 85, 17–33, 2008.
   PubMed Web of Science ®Google Scholar
• Stefanska B, Karlic H, Varga F, Fabianowska-Majewska K, and Haslberger A: Epigenetic mechanisms in anti-cancer actions of bioactive food components–the implications in cancer prevention. Br J Pharmacol 167, 279–297, 2012.
   PubMed Web of Science ®Google Scholar
• Tezcan G, Tunca B, Bekar A, Budak F, Sahin S, et al.: Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression. Am J Cancer Res 6, 572–590, 2014.
   Google Scholar
• Tunca B, Tezcan G, Cecener G, Egeli U, Ak S, et al.: Olea europaea leaf extract alters microRNA expression in human glioblastoma cells. J Cancer Res Clin Oncol 138, 1831–1844, 2012.
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, and Schneider EL: A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 175, 184–191, 1988.
   PubMed Web of Science ®Google Scholar
• Silva J, Freitas TRO, Marinho JR, Speit G, and Erdtmann B: An alkaline single cell gel electrophoresis (comet) assay for environmental biomonitoring with native rodents. Genet Mol Biol 23, 241–245, 2000.
   Web of Science ®Google Scholar
• John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al.: Human MicroRNA targets. PLoS Biol 2, e363, 2004.
   PubMed Web of Science ®Google Scholar
• Betel D, Koppal A, Agius P, Sander C, and Leslie C: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11, R90, 2010.
   PubMed Web of Science ®Google Scholar
• Schnekenburger M, Dicato M, and Diederich M: Plant-derived epigenetic modulators for cancer treatment and prevention. Biotechnol Adv 1, 1123–1132, 2014.
   Web of Science ®Google Scholar
• Topalović DŽ, Živković L, Čabarkapa A, Djelić N, Bajić V, et al.: Dry olive leaf extract counteracts L-thyroxine-induced genotoxicity in human peripheral blood leukocytes in vitro. Oxid Med Cell Longev 2015, 762192, 2015.
   PubMed Web of Science ®Google Scholar
• Tentori L, Lacal PM, and Graziani G: Challenging resistance mechanisms to therapies for metastatic melanoma. Trends Pharmacol Sci 34, 656–666, 2013.
   PubMed Web of Science ®Google Scholar
• Fares R, Bazzi S, Baydoun SE, and Abdel-Massih RM: The antioxidant and anti-proliferative activity of the Lebanese Olea europaea Extract. Plant Foods Hum Nutr 66, 58–63, 2011.
   PubMed Web of Science ®Google Scholar
• Reyes-Zurita FJ, Pachón-Peña G, Lizárraga D, Rufino-Palomares EE, Cascante M, et al.: The natural triterpene maslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism. BMC Cancer 27, 154, 2011.
   Web of Science ®Google Scholar
• Mijatovic SA, Timotijevic GS, Miljkovic DM, Radovic JM, Maksimovic-Ivanic DD, et al.: Multiple antimelanoma potential of dry olive leaf extract. Int J Cancer 15, 1955–1965, 2011.
   Web of Science ®Google Scholar